First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
Clinical trial NCT06239467 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06239467
- Sponsor
- OnKure, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-26
- Primary completion
- 2026-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.